B2M and colorectal cancer: Methylation of the B2M gene promoter was observed to interrelate with transcriptional inactivation and down-regulation of B2M expression in colorectal cancer featuring microsatellite instability (MSI) (40), which was up-regulated using the DNA methyltransferase inhibitor, DNMTi.